openPR Logo
Press release

Alopecia-Pipeline Review H2 2017

07-25-2017 11:22 PM CET | Health & Medicine

Press release from: ReportsWeb

ReportsWeb

ReportsWeb

ReportsWeb.com has announced the addition of the “Alopecia-Pipeline Review H2 2017” this report provides an overview of the Alopecia (Dermatology) pipeline landscape.

Alopecia is the partial or complete loss of hair especially on the scalp either in patches on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies irritants toxins burns injuries and infections.

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Alopecia-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Alopecia (Dermatology) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.

The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Pre-Registration Phase III Phase II Phase I IND/CTA Filed Preclinical and Discovery stages are 1 1 12 5 1 19 and 9 respectively. Similarly the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules respectively.

Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis..

For more information about this report at http://www.reportsweb.com/alopecia-pipeline-review-h2-2017

Report Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology) .
- The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description descriptive licensing and collaboration details R&D brief MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA) drug target route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)

Request a sample copy at http://www.reportsweb.com/inquiry&RW0001881442/sample

Reasons to buy

- Procure strategically important competitor information analysis and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology) .
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Key Company profiles
Aclaris Therapeutics Inc
Allergan Plc
Almirall SA
AndroScience Corp
Berg LLC
BiologicsMD Inc
BirchBioMed Inc
Brickell Biotech Inc
Bristol-Myers Squibb Company
Cassiopea SpA
Daewoong Pharmaceutical Co Ltd
Dong-A Socio Holdings Co Ltd
Handok Inc

Ask for Discount at http://www.reportsweb.com/inquiry&RW0001881442/discount

List of Tables
Number of Products under Development for Alopecia H2 2017
Number of Products under Development by Companies H2 2017
Number of Products under Development by Companies H2 2017 (Contd..1) H2 2017
Number of Products under Development by Universities/Institutes H2 2017
Products under Development by Companies H2 2017
Products under Development by Companies H2 2017 (Contd..1) H2 2017
Products under Development by Companies H2 2017 (Contd..2) H2 2017
Products under Development by Universities/Institutes H2 2017
Number of Products by Stage and Target H2 2017
Number of Products by Stage and Target H2 2017 (Contd..1) H2 2017
Number of Products by Stage and Mechanism of Action H2 2017
Number of Products by Stage and Mechanism of Action H2 2017 (Contd..1) H2 2017
Number of Products by Stage and Route of Administration H2 2017
Number of Products by Stage and Molecule Type H2 2017
Alopecia-Pipeline by Aclaris Therapeutics Inc H2 2017
Alopecia-Pipeline by Allergan Plc H2 2017
Alopecia-Pipeline by Almirall SA H2 2017
Alopecia-Pipeline by AndroScience Corp H2 2017
Alopecia-Pipeline by Berg LLC H2 2017
Alopecia-Pipeline by BiologicsMD Inc H2 2017
Alopecia-Pipeline by BirchBioMed Inc H2 2017
Alopecia-Pipeline by Brickell Biotech Inc H2 2017
Alopecia-Pipeline by Bristol-Myers Squibb Company H2 2017
Alopecia-Pipeline by Cassiopea SpA H2 2017

Purchase Complete Report at http://www.reportsweb.com/buy&RW0001881442/buy/2000

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support Vulvar Cancer is always available to help you on your research queries.

505, 6th floor, Amanora Township,
Amanora Chambers, East Block,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alopecia-Pipeline Review H2 2017 here

News-ID: 641211 • Views: 549

More Releases from ReportsWeb

North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy. The report provides in depth analysis on global renewable power market and

All 5 Releases


More Releases for Alopecia

Researchers Discover Potential of Alopecia Treatment Market
The Alopecia Treatment Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Alopecia Treatment Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for
Alopecia Market Size, Share & Trends| Industry Report 2026
The global Alopecia Market was valued at $21.60Billion in 2018 and is forecast to grow at a modest8.2 % CAGR between 2018 and 2025, culminating in 2026 global sales of $28.04 Billion. Alopecia is a disease which causes hair to fall in small patches with the unnoticeable time period of a human body. In this disease the immune system directly attacks to the hair follicles, resulting in hair losses, hair
Alopecia Drugs Market Outlook till 2018 to 2022 | By Alopecia Type Alopecia Area …
Market Research Future Published a Prime Research Report on Global Alopecia Drugs Market. The global Alopecia Drugs Market is expected to grow at a CAGR of 6.92% during the Period 2018 to 2022. “Alopecia Drugs Market” Completed Major Study of Alopecia Drugs in Market Research Future. This Report aim is Provide Insights about Factors Affecting the Market Growth. Market Scenario of Global Alopecia Drugs Market: Alopecia is loss of hair due to a
Alopecia Treatment Market - Global Forecast to 2026
Alopecia also called as hair-loss or baldness is a medical condition that refers to loss of hairs from head or any part of the body. The condition can occur in both male and female and at any age. There are five major type of alopecia namely; alopecia areata, androgenic alopecia, ciatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a common autoimmune disorder in which the immune system of
Alopecia Treatment Market - Global Forecast to 2026
Alopecia also called as hair-loss or baldness is a medical condition that refers to loss of hairs from head or any part of the body. The condition can occur in both male and female and at any age. There are five major type of alopecia namely; alopecia areata, androgenic alopecia, ciatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a common autoimmune disorder in which the immune system of
Alopecia Drugs Industry Analysis and Global Forecast to 2022
Alopecia Drugs Market is expected to reach around $ 11.8 billion by the end of the forecast period and is expected to grow at a CAGR of ~ 6.92%. The primary market drivers are genetics, increasing awareness, modern lifestyle changes, stress, drug-induced alopecia etc. The constraining factors are unethical spurious products, poor efficacy and efficiency of treatment resulting in poor economics to the patient, neglect of alopecia as it